An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer
Listen now
Description
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com Sarah LeBaron von Baeyer studied anthropology at Yale. Today she serves as the Director of Ethics Engagement at the new drug development company, Variant Bio, not a job she ever imagined at university.
More Episodes
Coming from the field of digital pathology, Joachim Schmid has a unique perspective on the evolution of multi-omics.  Schmid was recently appointed as Vice President of Multiomics Data Solutions at Illumina.In this episode, Theral dives into the burgeoning field of multi-omics—integrating data...
Published 11/21/24
Published 11/21/24
Dr. Mark Lewis is a well known GI oncologist at Intermountain Health in Salt Lake City, Utah. Gifted with a passionate communication style, he has over 93,000 Twitter followers. Next month, he will live-tweet his upcoming colonoscopy.   In this episode, Dr. Lewis joins Theral in our ongoing...
Published 11/14/24